March 18th 2025
A recent study reveals significantly elevated placental interleukin 6 and vascular endothelial growth factor receptor 2 messenger RNA expression in fetal death cases, highlighting inflammation and impaired fetal protection mechanisms.
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
Revi System shows efficacy against urgency urinary incontinence
March 12th 2025John PFA Heesakkers, MD, PhD, MBA, with Maastricht Universitair Medisch Centrum, highlights a study revealing that the Revi System significantly reduces urinary incontinence episodes, offering a side-effect-free alternative to traditional treatments with high patient satisfaction.
Understanding the Rates of Unplanned Pregnancy in the United States
March 11th 2025Panelists discuss how nearly 46% of pregnancies in the US are unplanned. Although this rate has declined, the US still has one of the highest rates of unplanned pregnancies in the world, particularly affecting minority and disadvantaged communities.
Researchers highlight risks of breastfeeding while taking Levetiracetam
March 11th 2025Shirley Wang, a PhD student in the School of Pharmacy at the University of Waterloo, discusses the findings on Levetiracetam’s safety during breastfeeding and how mothers can make informed decisions about medication use and infant health.
New pSNM system empowers patients in urge urinary incontinence treatment
March 6th 2025Jannah Thompson, MD, FPMRS, discusses how the Neuspera sacral neuromodulation system encourages patient involvement, improving long-term treatment success and offering broader applicability for those with urge urinary incontinence.
Jannah Thompson, MD, highlights battery free device for UUI management
March 5th 2025A new study on the Neuspera sacral neuromodulation system reveals that 84% of patients experienced significant symptom improvement, offering a minimally invasive, battery-free solution for urgency urinary incontinence.